Financing a Long-Term Care Home Acquisition

Financing a long-term care home acquisition usually means financing two different things at once, and lenders treat them differently. One is the licensed operating business — the bed licence, the funding envelope and the cash flow it produces. The other, where the buyer is also acquiring the property, is the real estate itself. A lender looking at the operating business is underwriting a regulated income stream and an operator’s track record; a lender looking at the real estate is underwriting a building and a location. Treating an acquisition financing package as a single request rather than recognizing these as two different lending problems is one of the more common ways a buyer underestimates how the financing side of the deal will actually be structured.

Real estate and the operating business are financed differently

That real estate and operator split shows up directly in how buyers structure the deal, and it shapes financing right alongside ownership. A REIT or real estate investor acquiring the building typically finances it the way it would any commercial real estate purchase, against the property itself, often with an operating partner in place under a long-term lease. An operator acquiring the licensed business — whether or not it also owns the real estate — is financed more on the strength of its regulated cash flow and its own operating track record than on the building’s resale value, because a lender knows a long-term care facility’s real estate has limited alternative use if the licence is not part of the deal. A buyer approaching a lender needs to be clear about which of these two profiles it fits, because a proposal that blurs the two tends to slow down underwriting rather than speed it up.

Why government-set funding cuts both ways in underwriting

Government-set funding complicates underwriting in ways that cut in both directions. On one hand, a per-diem funding stream is relatively predictable and not exposed to the demand swings an ordinary consumer business faces, which a lender can view favourably. On the other, that same funding is largely outside the operator’s control, which caps the upside a lender can credit toward debt service no matter how efficiently the home is run — a lender is not going to underwrite growth in revenue the operator cannot actually generate through better management. Case-mix acuity and the funding class the home qualifies for matter here too, since they set the ceiling on the revenue a lender will treat as reliable.

Compliance history affects financing, not just the sale

Compliance and inspection history affects financing the same way it affects the sale itself, because a lender is not going to commit funds to a deal where the change-of-licensee approval is genuinely in doubt. Expect a lender to ask for the same compliance and inspection records a careful buyer would already be reviewing in diligence, and expect financing commitments to carry conditions tied to that approval actually coming through — which is exactly where the mismatch between a financing commitment’s expiry date and the regulator’s own timeline becomes a real problem a buyer has to manage actively, not assume will resolve itself.

Vendor take-backs as a bridge through the approval gap

Vendor take-backs show up often in this sector, and they tend to sit specifically around the approval-timeline risk rather than simply filling a financing gap the way they might in an ordinary business sale. A seller willing to hold back part of the purchase price, contingent on or bridging through the change-of-licensee approval, gives a buyer room to secure permanent financing without racing a lender’s commitment deadline against a regulatory process neither party fully controls. Structuring that holdback correctly, with terms both sides can actually live with if approval takes longer than expected, is worth getting right early rather than treating it as a minor point in the purchase agreement.

Planning for a financing structure that survives delay

Because the approval process can run well beyond a typical financing commitment window, buyers commonly need to plan for a financing structure that survives delay — an extended commitment, a bridge facility, or financing conditioned explicitly on approval rather than on a fixed closing date. A lender unfamiliar with the sector may not build that flexibility in on its own, which is one reason working with a lender experienced in healthcare or institutional real estate financing tends to produce a smoother process than a generalist commercial lender working through the sector’s specifics for the first time.

Where buyers typically source financing

On the sources side, buyers typically draw on a mix of conventional bank and Crown-lender acquisition financing, such as facilities offered through the Business Development Bank of Canada, alongside vendor take-back terms and, for smaller or independent operators, federally backed small-business financing programs — though those programs are generally sized for smaller acquisitions and may not fit a larger chain purchase. Matching the financing structure to the buyer profile, the real estate versus operating split, and the approval timeline is a conversation worth having with a lender and legal advisor before an offer is finalized, not after.